ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Zou22c,Bivalent_3dose_CP_1,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_1,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_1,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_1,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_1,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_1,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_1,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_1,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_1,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_1,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_1,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_1,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_2,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_2,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20480,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_2,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_2,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_2,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_2,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_2,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_2,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_2,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_2,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_2,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_2,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_3,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_3,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_3,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_3,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_3,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_3,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_3,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_3,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_3,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_3,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_3,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_3,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_4,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_4,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_4,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_4,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_4,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_4,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_4,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_4,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_4,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_4,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_4,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_4,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_5,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_5,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_5,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_5,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_5,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_5,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_5,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_5,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_5,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_5,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_5,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_5,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_7,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_7,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_7,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_7,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_7,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_7,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_7,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_7,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_7,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_7,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_7,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_7,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_8,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_8,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_8,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_8,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_8,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_8,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_8,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_8,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_8,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_8,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_8,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_8,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_9,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_9,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_9,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_9,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_9,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_9,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_9,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_9,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_9,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_9,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_9,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_9,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_10,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_10,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_10,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_10,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_10,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_10,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_10,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_10,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_10,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_10,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_10,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_10,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_11,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_11,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_11,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_11,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_11,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_11,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_11,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_11,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_11,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_11,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_11,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_11,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_12,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_12,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40960,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_12,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_12,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20480,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_12,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_12,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,14482,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_12,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_12,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_12,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_12,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_12,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_12,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_13,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_13,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_13,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_13,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_13,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_13,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_13,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_13,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_13,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_13,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_13,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_13,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_14,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_14,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_14,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_14,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_14,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_14,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_14,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_14,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_14,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_14,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_14,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_14,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_15,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_15,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_15,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_15,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_15,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_15,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_15,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_15,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_15,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_15,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_15,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_15,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_16,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_16,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_16,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_16,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_16,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_16,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_16,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_16,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_16,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_16,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_16,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_16,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_17,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_17,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_17,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_17,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_17,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_17,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_17,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_17,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_17,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_17,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_17,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_17,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_18,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_18,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_18,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_18,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_18,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_18,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_18,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_18,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_18,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_18,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_18,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_18,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_19,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_19,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_19,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_19,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_19,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_19,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_19,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_19,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_19,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_19,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_19,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_19,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_20,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_20,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_20,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_20,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_20,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_20,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_20,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_20,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_20,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_20,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_20,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_20,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_21,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_21,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_21,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_21,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_21,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_21,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_21,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_21,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_21,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_21,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_21,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_21,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_22,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_22,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_22,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_22,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_22,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_22,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_22,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_22,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_22,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_22,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_22,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_22,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_23,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_23,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_23,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_23,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_23,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_23,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_23,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_23,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_23,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_23,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_23,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_23,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_24,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_24,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20480,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_24,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_24,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_24,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_24,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_24,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_24,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_24,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_24,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_24,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_24,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_25,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_25,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_25,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_25,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_25,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_25,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_25,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_25,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_25,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_25,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_25,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_25,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_26,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_26,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_26,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_26,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_26,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_26,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_26,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_26,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_26,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_26,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_26,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_26,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_27,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_27,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_27,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_27,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_27,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_27,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_27,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_27,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_27,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_27,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_27,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_27,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_28,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_28,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_28,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_28,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_28,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_28,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_28,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_28,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_28,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_28,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_28,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_28,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_29,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_29,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_29,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_29,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_29,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_29,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_29,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_29,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_29,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_29,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_29,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_29,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_30,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_30,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_30,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_30,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_30,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_30,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_30,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_30,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_30,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_30,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_30,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_30,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_31,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_31,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_31,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_31,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_31,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_31,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_31,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_31,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_31,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_31,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_31,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_31,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_32,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_32,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_32,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_32,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_32,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_32,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_32,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_32,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_32,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_32,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_32,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_32,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_34,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_34,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_34,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_34,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_34,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_34,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_34,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_34,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_34,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_34,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_34,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_34,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_35,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_35,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_35,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_35,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_35,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_35,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_35,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_35,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_35,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_35,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_35,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_35,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_36,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_36,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_36,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_36,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_36,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_36,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_36,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_36,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_36,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_36,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_36,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_36,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_37,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_37,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_37,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_37,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_37,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_37,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_37,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_37,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_37,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_37,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_37,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_37,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_38,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_38,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_38,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_38,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_38,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_38,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_38,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_38,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_38,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_38,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_38,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_38,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_39,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_39,WA1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_39,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_39,BA.4/5 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_39,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_39,BA.4.6 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_39,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_39,BA.2.75.2 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_39,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_39,BQ.1.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_3dose_CP_39,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,Bivalent_4dose_CP_39,XBB.1 Spike,Supplementary Table 3,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_1,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_1,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_1,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_1,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_1,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_1,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_1,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_1,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_1,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_1,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_1,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_1,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_2,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_2,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_2,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_2,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_2,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_2,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_2,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_2,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_2,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_2,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_2,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_2,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_3,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_3,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_3,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_3,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_3,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_3,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_3,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_3,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_3,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_3,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_3,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_3,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_4,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_4,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_4,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_4,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_4,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_4,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_4,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_4,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_4,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_4,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_4,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_4,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_5,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_5,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_5,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_5,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_5,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_5,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_5,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_5,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_5,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_5,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_5,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_5,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_6,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_6,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_6,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_6,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_6,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_6,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_6,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_6,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_6,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_6,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_6,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_6,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_7,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_7,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_7,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_7,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_7,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_7,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_7,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_7,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_7,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_7,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_7,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_7,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_8,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_8,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_8,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_8,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_8,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_8,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_8,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,^10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_8,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_8,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_8,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_8,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_8,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_9,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_9,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_9,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_9,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_9,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_9,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_9,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_9,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_9,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_9,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_9,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_9,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_10,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_10,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_10,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_10,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_10,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_10,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_10,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_10,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_10,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_10,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_10,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_10,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_11,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_11,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_11,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_11,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_11,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_11,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_11,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_11,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_11,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_11,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_11,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_11,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_12,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20480,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_12,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20480,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_12,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_12,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_12,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_12,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_12,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_12,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_12,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_12,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_12,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_12,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_13,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_13,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_13,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_13,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_13,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_13,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_13,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_13,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_13,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_13,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_13,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_13,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_14,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_14,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_14,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_14,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_14,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_14,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_14,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_14,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_14,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_14,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_14,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_14,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_15,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_15,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_15,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_15,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_15,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_15,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_15,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_15,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_15,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_15,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_15,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_15,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_16,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_16,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_16,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_16,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_16,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_16,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_16,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_16,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_16,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_16,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_16,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_16,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_17,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_17,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_17,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_17,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_17,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_17,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_17,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_17,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_17,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_17,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_17,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_17,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_18,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_18,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_18,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_18,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_18,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_18,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_18,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_18,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_18,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_18,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_18,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_18,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_19,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_19,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_19,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_19,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_19,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_19,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_19,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_19,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_19,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_19,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_19,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_19,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_20,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_20,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_20,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_20,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_20,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_20,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_20,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_20,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_20,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_20,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_20,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_20,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_21,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_21,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,7241,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_21,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_21,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_21,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_21,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_21,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_21,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_21,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_21,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_21,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_21,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_22,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_22,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_22,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_22,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_22,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_22,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_22,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_22,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_22,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_22,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_22,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_22,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_23,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_23,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_23,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_23,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_23,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_23,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_23,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_23,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_23,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_23,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_23,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_23,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_24,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_24,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_24,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_24,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_24,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_24,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_24,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_24,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_24,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_24,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_24,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_24,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_25,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_25,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_25,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_25,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_25,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_25,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_25,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_25,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_25,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_25,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_25,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_25,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_26,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_26,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_26,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_26,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_26,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_26,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_26,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_26,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_26,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_26,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_26,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_26,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_27,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_27,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_27,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_27,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_27,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_27,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_27,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_27,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_27,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_27,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_27,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_27,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_28,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_28,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_28,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_28,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_28,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_28,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_28,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_28,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_28,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,57,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_28,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_28,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_28,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_29,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_29,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_29,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_29,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_29,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_29,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_29,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_29,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_29,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_29,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_29,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_29,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_30,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_30,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_30,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_30,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_30,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_30,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_30,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_30,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_30,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_30,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_30,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_30,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_31,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_31,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_31,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_31,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_31,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_31,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_31,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_31,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_31,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_31,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_31,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_31,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_32,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_32,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_32,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_32,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_32,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_32,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_32,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_32,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_32,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_32,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_32,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_32,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_33,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_33,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10240,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_33,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_33,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_33,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_33,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1810,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_33,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_33,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_33,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_33,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_33,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_33,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_34,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_34,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_34,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_34,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_34,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_34,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_34,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_34,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_34,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_34,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_34,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_34,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_35,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_35,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_35,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_35,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_35,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_35,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_35,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_35,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_35,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_35,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_35,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_35,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_36,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_36,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,5120,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_36,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_36,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_36,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_36,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_36,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_36,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_36,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_36,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_36,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_36,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,226,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_37,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,320,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_37,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_37,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_37,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_37,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_37,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_37,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_37,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_37,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_37,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_37,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_37,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_38,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_38,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,1280,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_38,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_38,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_38,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_38,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_38,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_38,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_38,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_38,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_38,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_38,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_39,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,905,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_39,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,3620,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_39,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,113,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_39,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,453,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_39,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_39,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_39,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_39,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,80,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_39,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_39,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_39,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_39,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_40,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,640,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_40,WA1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,2560,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_40,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_40,BA.4/5 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_40,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_40,BA.4.6 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,160,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_40,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_40,BA.2.75.2 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,40,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_40,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_40,BQ.1.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,28,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_3dose_CP_40,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,10,1,20480,20,NULL,2022-11-21
Zou22c,BNT162b2_4dose_CP_40,XBB.1 Spike,Supplementary Table 4,SARS-CoV-2 recombinant,NT50,20,1,20480,20,NULL,2022-11-21
